216 related articles for article (PubMed ID: 21216229)
1. Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells.
Wu CC; Yu CT; Chang GC; Lai JM; Hsu SL
Biochem Biophys Res Commun; 2011 Feb; 405(2):168-72. PubMed ID: 21216229
[TBL] [Abstract][Full Text] [Related]
2. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J
Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657
[TBL] [Abstract][Full Text] [Related]
4. Aurora-A kinase regulates NF-kappaB activity: lessons from combination studies.
Linardopoulos S
J BUON; 2007 Sep; 12 Suppl 1():S67-70. PubMed ID: 17935280
[TBL] [Abstract][Full Text] [Related]
5. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells.
Chang GC; Yu CT; Tsai CH; Tsai JR; Chen JC; Wu CC; Wu WJ; Hsu SL
Eur J Pharmacol; 2008 Dec; 600(1-3):37-44. PubMed ID: 18973751
[TBL] [Abstract][Full Text] [Related]
6. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
[TBL] [Abstract][Full Text] [Related]
8. p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer.
Rho JK; Choi YJ; Ryoo BY; Na II; Yang SH; Kim CH; Lee JC
Cancer Res; 2007 Feb; 67(3):1163-9. PubMed ID: 17283151
[TBL] [Abstract][Full Text] [Related]
9. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase.
Zhang L; Cui R; Cheng X; Du J
Cancer Res; 2005 Jan; 65(2):457-64. PubMed ID: 15695387
[TBL] [Abstract][Full Text] [Related]
10. Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha.
Briassouli P; Chan F; Savage K; Reis-Filho JS; Linardopoulos S
Cancer Res; 2007 Feb; 67(4):1689-95. PubMed ID: 17308110
[TBL] [Abstract][Full Text] [Related]
11. Lapatinib inhibits the activation of NF-κB through reducing phosphorylation of IκB-α in breast cancer cells.
Ma C; Zuo W; Wang X; Wei L; Guo Q; Song X
Oncol Rep; 2013 Feb; 29(2):812-8. PubMed ID: 23229346
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.
Shao J; Fujiwara T; Kadowaki Y; Fukazawa T; Waku T; Itoshima T; Yamatsuji T; Nishizaki M; Roth JA; Tanaka N
Oncogene; 2000 Feb; 19(6):726-36. PubMed ID: 10698490
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of sensitivity to tumor necrosis factor alpha in non-small cell lung cancer cells with acquired resistance to gefitinib.
Ando K; Ohmori T; Inoue F; Kadofuku T; Hosaka T; Ishida H; Shirai T; Okuda K; Hirose T; Horichi N; Nishio K; Saijo N; Adachi M; Kuroki T
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8872-9. PubMed ID: 16361577
[TBL] [Abstract][Full Text] [Related]
14. p53 gene expression and 2-methoxyestradiol treatment differentially induce nuclear factor kappa B activation in human lung cancer cells with different p53 phenotypes.
Rath PC; Mukhopadhyay T
DNA Cell Biol; 2009 Dec; 28(12):615-23. PubMed ID: 19715480
[TBL] [Abstract][Full Text] [Related]
15. A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation.
Jeong JB; Yang X; Clark R; Choi J; Baek SJ; Lee SH
Carcinogenesis; 2013 Oct; 34(10):2350-60. PubMed ID: 23784084
[TBL] [Abstract][Full Text] [Related]
16. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
[TBL] [Abstract][Full Text] [Related]
17. Aurora-a contributes to radioresistance by increasing NF-kappaB DNA binding.
Oh ET; Byun MS; Lee H; Park MT; Jue DM; Lee CW; Lim BU; Park HJ
Radiat Res; 2010 Sep; 174(3):265-73. PubMed ID: 20726719
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
20. Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction.
Kim MJ; Yun HS; Hong EH; Lee SJ; Baek JH; Lee CW; Yim JH; Kim JS; Park JK; Um HD; Hwang SG
Cancer Lett; 2013 Oct; 339(1):15-24. PubMed ID: 23900080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
